Embodiments of the invention are directed to identifying or treating a patient that would benefit from phosphodiesterase inhibitor therapy.Selon ses modes de réalisation, linvention porte sur lidentification ou le traitement dun patient susceptible de bénéficier dune thérapie inhibitrice de la phosphodiestérase.